SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15 (d) of the
Securities Exchange Act of 1934
| | | |
| Date of Report (Date of earliest event reported): | February 27, 2003 |
United Therapeutics Corporation
(Exact Name of Registrant as Specified in Charter)
| | | | | |
| Delaware | | 000-26301 | | 52-1984749 |
| |
| |
|
| (State or Other | | (Commission | | (I.R.S. Employer |
| Jurisdiction of | | File Number) | | Identification Number) |
| Incorporation) | | | | |
| | | |
| 1110 Spring Street | | |
| Silver Spring, MD | | 20910 |
| |
|
| (Address of Principal Executive Offices) | | (Zip Code) |
Registrant’s telephone number, including area code:
(301) 608-9292
Item 5. Other Events.
On March 3, 2003, United Therapeutics Corporation (the “Company”) issued a press release announcing the appointment of R. Paul Gray to the Company’s Board of Directors and as Chairman of the Audit Committee, and also announcing the resignation of Michael P. Joseph from the Company’s Board of Directors. A copy of the press release is attached hereto and incorporated herein by this reference.
Item 7. Exhibits
(c) Exhibits
| | | |
| Exhibit No. | | Description of Exhibit |
| |
| 99.1 | | Press release dated March 3, 2003 |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | | | | |
| | | | | | | UNITED THERAPEUTICS CORPORATION |
| |
| Dated: March 3, 2003 | | By: | | /s/ Paul Mahon
Name: Paul A. Mahon
Title: SVP and General Counsel |
EXHIBIT INDEX
| | | |
| Exhibit No. | | Description of Exhibit |
| |
| 99.1 | | Press release dated March 3, 2003 |
